According to the latest financial report of Bio-Rad Laboratories-B, the latest earnings per share (TTM) for the company is 23.34. Investing in companies with strong earnings per share can potentially provide higher returns.
Interested in knowing about Bio-Rad Laboratories-B's free cash flow? The latest report shows it as 99.97M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Bio-Rad Laboratories-B shows that the company's current ratio is 6.14, indicating healthy liquidity.
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Bio-Rad Laboratories-B, the quick ratio is 4.19, indicating that the company can meet its short-term debt obligations.
Want to learn more about the financial health of Bio-Rad Laboratories-B? The latest ROE figure is 9.16%, indicating that the company has stable profitability.
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Bio-Rad Laboratories-B, the total asset return on investment (ROA) is 6.44%.
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Bio-Rad Laboratories-B's latest financial report to see how their gross margin is doing - currently at 54.78%.
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Bio-Rad Laboratories-B, the net profit margin is 100.53%, which is a good sign for its profitability.